EquityBulls

Latest News

Keywords Selected: Tablets

Stock Report

NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
Lupin launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Shilpa Medicare announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non‐Alcoholic Fatty Liver Disease in India
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
Lupin launches Prucalopride tablets in the United States
Lupin receives approval from U.S. FDA for Prucalopride Tablets
J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
Indoco Remedies Ltd announces the first day launch of Ticagrelor filmcoated tablets through its subsidiary in the United Kingdom
Zydus receives tentative approval from USFDA for Rifaximin Tablets, 550 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP
Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg
Lupin receives approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg
Lupin launches Eslicarbazepine Acetate Tablets in the United States
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg
Lupin receives approval from U.S. FDA for Tolvaptan Tablets
Eugia Pharma receives USFDA Approval for Dasatinib Tablets